Hypothalamic Obesity after Craniopharyngioma: Mechanisms, Diagnosis, and Treatment
Open Access
- 1 January 2011
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 2, 60
- https://doi.org/10.3389/fendo.2011.00060
Abstract
Obesity is a common complication after craniopharyngioma therapy, occurring in up to 75% of survivors. Its weight gain is unlike that of normal obesity, in that it occurs even with caloric restriction, and attempts at lifestyle modification are useless to prevent or treat the obesity. The pathogenesis of this condition involves the inability to transduce afferent hormonal signals of adiposity, in effect mimicking a state of CNS starvation. Efferent sympathetic activity drops, resulting in malaise and reduced energy expenditure, and vagal activity increases, resulting in increased insulin secretion and adipogenesis. Lifestyle intervention is essentially useless in this syndrome, termed “hypothalamic obesity”. Pharmacologic treatment is also difficult, consisting of adrenergics to mimic sympathetic activity, or suppression of insulin secretion with octreotide, or both. Recently, bariatric surgery (Roux-en-Y gastric bypass, laparoscopic gastric banding, truncal vagotomy) have also been attempted with variable results. Early and intensive management is required to mitigate the obesity and its negative consequences.This publication has 79 references indexed in Scilit:
- Delayed ghrelin suppression following oral glucose tolerance test in children and adolescents with hypothalamic injury secondary to craniopharyngioma compared with obese controlsPediatric Obesity, 2011
- Hypothalamic Obesity following Craniopharyngioma Surgery: Results of a Pilot Trial of Combined Diazoxide and Metformin TherapyInternational Journal of Pediatric Endocrinology, 2011
- Gastric bypass surgery for treatment of hypothalamic obesity after craniopharyngioma therapyNature Clinical Practice Endocrinology & Metabolism, 2007
- Racial and etiopathologic dichotomies in insulin hypersecretion and resistance in obese childrenThe Journal of Pediatrics, 2005
- Role of the β3-Adrenergic Receptor and/or a Putative β4-Adrenergic Receptor on the Expression of Uncoupling Proteins and Peroxisome Proliferator-Activated Receptor-γ Coactivator-1Biochemical and Biophysical Research Communications, 1999
- Muscarinic Stimulation Increases Na+Entry in Pancreatic B-Cells by a Mechanism Other than the Emptying of Intracellular Ca2+PoolsBiochemical and Biophysical Research Communications, 1996
- Attentional Processing in Hyperthyroid Children Before and After TreatmentJournal of Pediatric Endocrinology and Metabolism, 1996
- Children with CraniopharyngiomaActa Paediatrica, 1988
- TRUNCAL VAGOTOMY IN HYPOTHALAMIC OBESITYThe Lancet, 1983
- Consequences of Ventromedial Hypothalamic Lesions upon Insulin and Glucagon Secretion by Subsequently Isolated Perfused Pancreases in the RatJCI Insight, 1980